Recent years have witnessed groundbreaking progresses in the read more field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as hopeful candidates, showing exceptional results in clinical trials. … Read More